Growth Metrics

Anavex Life Sciences (AVXL) Cash & Equivalents Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -68.22%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 988.88%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 15.64%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.77%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.50%
7 Evaxion A 62.56 Bn 62.54 Bn - 3.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 67.78%
10 Anavex Life Sciences 266.20 Mn 134.45 Mn - 9.09%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 9.09%
Sep 30, 2025 -22.40%
Jun 30, 2025 -27.09%
Mar 31, 2025 -16.94%
Dec 31, 2024 -15.99%
Sep 30, 2024 -12.47%
Jun 30, 2024 -10.37%
Mar 31, 2024 -9.18%
Dec 31, 2023 0.10%
Sep 30, 2023 1.25%
Jun 30, 2023 1.06%
Mar 31, 2023 0.08%
Dec 31, 2022 -4.98%
Sep 30, 2022 -1.94%
Jun 30, 2022 -2.77%
Mar 31, 2022 102.14%
Dec 31, 2021 219.16%
Sep 30, 2021 420.04%
Jun 30, 2021 470.47%
Mar 31, 2021 185.58%
Dec 31, 2020 72.47%
Sep 30, 2020 31.84%
Jun 30, 2020 29.98%
Mar 31, 2020 36.52%
Dec 31, 2019 32.55%
Sep 30, 2019 -3.25%
Jun 30, 2019 -17.73%
Mar 31, 2019 -24.16%
Dec 31, 2018 -26.15%
Sep 30, 2018 -16.43%
Jun 30, 2018 4.17%
Mar 31, 2018 9.87%
Dec 31, 2017 32.55%
Sep 30, 2017 198.69%
Jun 30, 2017 154.89%
Sep 30, 2016 -39.92%
Jun 30, 2016 22.18%
Sep 30, 2015 110.56%
Jun 30, 2015 -2.67%
Mar 31, 2015 -31.36%
Dec 31, 2014 7,177.33%
Sep 30, 2014 2,004.52%
Jun 30, 2014 497,145.05%
Mar 31, 2014 1,887,694.25%
Dec 31, 2013 20.23%
Sep 30, 2013 2,937.09%
Jun 30, 2013 -90.96%
Mar 31, 2013 -99.73%
Dec 31, 2012 778.83%
Sep 30, 2012 -91.57%
Jun 30, 2012 -98.51%
Mar 31, 2012 4,806.54%
Sep 30, 2011 -49.11%